251 related articles for article (PubMed ID: 21518850)
1. Cell cholesterol modulates metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 (LRP-1) and clearance function.
Selvais C; D'Auria L; Tyteca D; Perrot G; Lemoine P; Troeberg L; Dedieu S; Noël A; Nagase H; Henriet P; Courtoy PJ; Marbaix E; Emonard H
FASEB J; 2011 Aug; 25(8):2770-81. PubMed ID: 21518850
[TBL] [Abstract][Full Text] [Related]
2. Metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 ectodomain decreases endocytic clearance of endometrial matrix metalloproteinase-2 and -9 at menstruation.
Selvais C; Gaide Chevronnay HP; Lemoine P; Dedieu S; Henriet P; Courtoy PJ; Marbaix E; Emonard H
Endocrinology; 2009 Aug; 150(8):3792-9. PubMed ID: 19406945
[TBL] [Abstract][Full Text] [Related]
3. The low density lipoprotein receptor-related protein LRP is regulated by membrane type-1 matrix metalloproteinase (MT1-MMP) proteolysis in malignant cells.
Rozanov DV; Hahn-Dantona E; Strickland DK; Strongin AY
J Biol Chem; 2004 Feb; 279(6):4260-8. PubMed ID: 14645246
[TBL] [Abstract][Full Text] [Related]
4. Cellular Cholesterol Distribution Influences Proteolytic Release of the LRP-1 Ectodomain.
Dekky B; Wahart A; Sartelet H; Féré M; Angiboust JF; Dedieu S; Piot O; Devy J; Emonard H
Front Pharmacol; 2016; 7():25. PubMed ID: 26903870
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Shedding of Low-Density Lipoprotein Receptor-Related Protein 1 Reverses Cartilage Matrix Degradation in Osteoarthritis.
Yamamoto K; Santamaria S; Botkjaer KA; Dudhia J; Troeberg L; Itoh Y; Murphy G; Nagase H
Arthritis Rheumatol; 2017 Jun; 69(6):1246-1256. PubMed ID: 28235248
[TBL] [Abstract][Full Text] [Related]
6. Shedding of low-density lipoprotein receptor–related protein-1 in acute respiratory distress syndrome.
Wygrecka M; Wilhelm J; Jablonska E; Zakrzewicz D; Preissner KT; Seeger W; Guenther A; Markart P
Am J Respir Crit Care Med; 2011 Aug; 184(4):438-48. PubMed ID: 21471105
[TBL] [Abstract][Full Text] [Related]
7. MT1-MMP Expression Levels and Catalytic Functions Dictate LDL Receptor-Related Protein-1 Ligand Internalization Capacity in U87 Glioblastoma Cells.
Pratt J; Haidara K; Annabi B
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430705
[TBL] [Abstract][Full Text] [Related]
8. Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases.
Zhang L; Bukulin M; Kojro E; Roth A; Metz VV; Fahrenholz F; Nawroth PP; Bierhaus A; Postina R
J Biol Chem; 2008 Dec; 283(51):35507-16. PubMed ID: 18952609
[TBL] [Abstract][Full Text] [Related]
9. TIMP-3 facilitates binding of target metalloproteinases to the endocytic receptor LRP-1 and promotes scavenging of MMP-1.
Carreca AP; Pravatà VM; Markham M; Bonelli S; Murphy G; Nagase H; Troeberg L; Scilabra SD
Sci Rep; 2020 Jul; 10(1):12067. PubMed ID: 32694578
[TBL] [Abstract][Full Text] [Related]
10. MT1-MMP shedding involves an ADAM and is independent of its localization in lipid rafts.
Toth M; Sohail A; Mobashery S; Fridman R
Biochem Biophys Res Commun; 2006 Nov; 350(2):377-84. PubMed ID: 17007816
[TBL] [Abstract][Full Text] [Related]
11. Extracellular engagement of ADAM12 induces clusters of invadopodia with localized ectodomain shedding activity.
Albrechtsen R; Stautz D; Sanjay A; Kveiborg M; Wewer UM
Exp Cell Res; 2011 Jan; 317(2):195-209. PubMed ID: 20951132
[TBL] [Abstract][Full Text] [Related]
12. Membrane type 1 matrix metalloproteinase (MT1-MMP/MMP-14) cleaves and releases a 22-kDa extracellular matrix metalloproteinase inducer (EMMPRIN) fragment from tumor cells.
Egawa N; Koshikawa N; Tomari T; Nabeshima K; Isobe T; Seiki M
J Biol Chem; 2006 Dec; 281(49):37576-85. PubMed ID: 17050542
[TBL] [Abstract][Full Text] [Related]
13. Low density lipoprotein receptor-related protein mediates endocytic clearance of pro-MMP-2.TIMP-2 complex through a thrombospondin-independent mechanism.
Emonard H; Bellon G; Troeberg L; Berton A; Robinet A; Henriet P; Marbaix E; Kirkegaard K; Patthy L; Eeckhout Y; Nagase H; Hornebeck W; Courtoy PJ
J Biol Chem; 2004 Dec; 279(52):54944-51. PubMed ID: 15489233
[TBL] [Abstract][Full Text] [Related]
14. Increased TIMP-3 expression alters the cellular secretome through dual inhibition of the metalloprotease ADAM10 and ligand-binding of the LRP-1 receptor.
Scilabra SD; Pigoni M; Pravatá V; Schätzl T; Müller SA; Troeberg L; Lichtenthaler SF
Sci Rep; 2018 Oct; 8(1):14697. PubMed ID: 30279425
[TBL] [Abstract][Full Text] [Related]
15. Dissecting the interaction between tissue inhibitor of metalloproteinases-3 (TIMP-3) and low density lipoprotein receptor-related protein-1 (LRP-1): Development of a "TRAP" to increase levels of TIMP-3 in the tissue.
Scilabra SD; Yamamoto K; Pigoni M; Sakamoto K; Müller SA; Papadopoulou A; Lichtenthaler SF; Troeberg L; Nagase H; Kadomatsu K
Matrix Biol; 2017 May; 59():69-79. PubMed ID: 27476612
[TBL] [Abstract][Full Text] [Related]
16. Activation of MMP-9 by membrane type-1 MMP/MMP-2 axis stimulates tumor metastasis.
Li Z; Takino T; Endo Y; Sato H
Cancer Sci; 2017 Mar; 108(3):347-353. PubMed ID: 27987367
[TBL] [Abstract][Full Text] [Related]
17. A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16.
Gough PJ; Garton KJ; Wille PT; Rychlewski M; Dempsey PJ; Raines EW
J Immunol; 2004 Mar; 172(6):3678-85. PubMed ID: 15004171
[TBL] [Abstract][Full Text] [Related]
18. Cellular uptake of proMMP-2:TIMP-2 complexes by the endocytic receptor megalin/LRP-2.
Johanns M; Lemoine P; Janssens V; Grieco G; Moestrup SK; Nielsen R; Christensen EI; Courtoy PJ; Emonard H; Marbaix E; Henriet P
Sci Rep; 2017 Jun; 7(1):4328. PubMed ID: 28659595
[TBL] [Abstract][Full Text] [Related]
19. Tissue-type plasminogen activator acts as a cytokine that triggers intracellular signal transduction and induces matrix metalloproteinase-9 gene expression.
Hu K; Yang J; Tanaka S; Gonias SL; Mars WM; Liu Y
J Biol Chem; 2006 Jan; 281(4):2120-7. PubMed ID: 16303771
[TBL] [Abstract][Full Text] [Related]
20. Constitutive and induced CD44 shedding by ADAM-like proteases and membrane-type 1 matrix metalloproteinase.
Nakamura H; Suenaga N; Taniwaki K; Matsuki H; Yonezawa K; Fujii M; Okada Y; Seiki M
Cancer Res; 2004 Feb; 64(3):876-82. PubMed ID: 14871815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
